Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas S Jacoby

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Medical Clinics of North America|March 1, 2022
PrefaceDouglas S Jacoby
Archives of Internal Medicine|May 28, 2003
Renin-angiotensin system and atherothrombotic disease: from genes to treatmentDouglas S Jacoby, Daniel J Rader
European Heart Journal|October 16, 2016
Improving cardiovascular outcomes by intensifying low density lipoprotein lowering therapy in high-risk patientsDouglas S Jacoby, Daniel J Rader
Current Cardiology Reports|May 7, 2021
The Use of Subclinical Atherosclerosis Imaging to Guide Preventive Cardiology ManagementMeshal Soni, Maxwell Ambrosino, Douglas S Jacoby
Current Atherosclerosis Reports|December 10, 2003
Noninvasive atherosclerosis imaging for predicting cardiovascular events and assessing therapeutic interventionsDouglas S Jacoby, Emile R Mohler III, Daniel J Rader
Journal of Clinical Lipidology|June 16, 2015
Updated cholesterol guidelines and intensity of statin therapyVincent Nguyen, Emil M deGoma, Erik Hossain, et al.
Journal of Clinical Lipidology|September 25, 2024
Real-world experience of inclisiran prescription at the University of Pennsylvania Health SystemsNicole M Wei, Robert F Tobin, Douglas S Jacoby, et al.
Reviews in Cardiovascular Medicine|February 10, 2015
Advanced lipid testing: when, why, and in whom?Karol E Watson, Eric H Stocker, Douglas S Jacoby, et al.
The American Journal of Cardiology|December 21, 2022
Post-Acute Coronary Syndrome Disparities in Guideline-Directed Lipid Therapy and Insufficient Achievement of Optimal Low-Density LipoproteinMaxwell Ambrosino, Sydney Emerson, Lauren Catalano, et al.
Journal of the American College of Cardiology|November 9, 2022
Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory BiomarkersLuke J Laffin, Dennis Bruemmer, Michelle Garcia, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Medical Clinics of North America|March 1, 2022
PrefaceDouglas S Jacoby
Archives of Internal Medicine|May 28, 2003
Renin-angiotensin system and atherothrombotic disease: from genes to treatmentDouglas S Jacoby, Daniel J Rader
European Heart Journal|October 16, 2016
Improving cardiovascular outcomes by intensifying low density lipoprotein lowering therapy in high-risk patientsDouglas S Jacoby, Daniel J Rader
Current Cardiology Reports|May 7, 2021
The Use of Subclinical Atherosclerosis Imaging to Guide Preventive Cardiology ManagementMeshal Soni, Maxwell Ambrosino, Douglas S Jacoby
Current Atherosclerosis Reports|December 10, 2003
Noninvasive atherosclerosis imaging for predicting cardiovascular events and assessing therapeutic interventionsDouglas S Jacoby, Emile R Mohler III, Daniel J Rader
Journal of Clinical Lipidology|June 16, 2015
Updated cholesterol guidelines and intensity of statin therapyVincent Nguyen, Emil M deGoma, Erik Hossain, et al.
Journal of Clinical Lipidology|September 25, 2024
Real-world experience of inclisiran prescription at the University of Pennsylvania Health SystemsNicole M Wei, Robert F Tobin, Douglas S Jacoby, et al.
Reviews in Cardiovascular Medicine|February 10, 2015
Advanced lipid testing: when, why, and in whom?Karol E Watson, Eric H Stocker, Douglas S Jacoby, et al.
The American Journal of Cardiology|December 21, 2022
Post-Acute Coronary Syndrome Disparities in Guideline-Directed Lipid Therapy and Insufficient Achievement of Optimal Low-Density LipoproteinMaxwell Ambrosino, Sydney Emerson, Lauren Catalano, et al.
Journal of the American College of Cardiology|November 9, 2022
Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory BiomarkersLuke J Laffin, Dennis Bruemmer, Michelle Garcia, et al.
Pageof 2